Waterbury AL, Iram I, Liau BB. Building the first base editors. Nature chemical biology. 2025;21(1):16-17. doi:10.1038/s41589-024-01790-3
Chemical Biology and Therapeutics Science Program
Matuszek Ż, Arbab M, Kesavan M, et al. Base editing of trinucleotide repeats that cause Huntington’s disease and Friedreich’s ataxia reduces somatic repeat expansions in patient cells and in mice. Nature genetics. 2025. doi:10.1038/s41588-025-02172-8
Chan A, Kirtane AR, Qu QR, et al. Designing lipid nanoparticles using a transformer-based neural network. Nature nanotechnology. 2025. doi:10.1038/s41565-025-01975-4
Witte IP, Lampe GD, Eitzinger S, et al. Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase. Science (New York, N.Y.). 2025;388(6748):eadt5199. doi:10.1126/science.adt5199
Sadagopan A, Carson M, Zamurs EJ, et al. Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs. Nature chemical biology. 2025. doi:10.1038/s41589-025-02051-7
Barta P, Garnar-Wortzel L, Bishop T, et al. A chemical-genetic interaction between PAF1 and ENL/AF9 YEATS inhibition. RSC chemical biology. 2025. doi:10.1039/d5cb00233h
PMCID
PMC12550596
Mody AC, Ramirez DH, Woo CM. Targeted protein O-GlcNAc reveals transcriptional functions for O-GlcNAc. Cell chemical biology. 2025. doi:10.1016/j.chembiol.2025.11.003
Abutaleb N, Gao X, Bedapudi A, et al. Adenine base editing rescues pathogenic phenotypes in tissue engineered vascular model of Hutchinson-Gilford progeria syndrome. APL bioengineering. 2025;9(1):016110. doi:10.1063/5.0244026
Khirallah J, Bloomer H, Wich D, et al. In vivo base editing of Angptl3 via lipid nanoparticles to treat cardiovascular disease. Molecular therapy. Nucleic acids. 2025;36(2):102486. doi:10.1016/j.omtn.2025.102486
Lloyd HC, Li Y, Payne C, et al. A method for the detection and enrichment of endogenous cereblon substrates. bioRxiv : the preprint server for biology. 2025. doi:10.1101/2025.03.24.645063